Conversion From Cyclosporine to Tacrolimus for Chronic Allograft Nephropathy

Transplantation Proceedings

Volumn 39, Issue 5, 2007, Pages 1402-1405

  Ji, S M ^a   Li, L S ^b   Sha, G Z ^a   Chen, J S ^a   Liu, Z H ^b  

^a JINLING HOSPITAL   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ADULT; ANOREXIA; ARTICLE; BLOATING; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIARRHEA; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GLUCAGON BLOOD LEVEL; HEMODIALYSIS; HIRSUTISM; HUMAN; HYPERGLYCEMIA; HYPERPLASIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROTEINURIA; TREMOR;

ADULT; BLOOD PRESSURE; CREATININE; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34250201016     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.11.030     Document Type: Article

References (19)

1. Joosten S.A., Van kooten C., Sijpkens Y.M.J., et al. The pathobiology of chronic allograft nephropathy: immune-mediated damage and accelerated aging. Kidney Int 65 (2004) 1556
2. Orosz C.G. Advances in the study of chronic allograft rejection. Current Opinion in Organ Transplantation 8 (2003) 167
3. Scherer A., Krause A., Walker J., et al. Early prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsies. Transplantation 75 (2003) 1323
4. Paul L.C., and de Fijter J.H. Cyclosporine induced renal dysfunction. Transplant Proc 36 suppl 2 (2004) 224S
5. Shu-ming J., Li-ping Y., Guang Y., et al. Clinical study on the course delay of grafted renal function by tacrolimus. Chin J Organ Transplant 21 (2000) 291
6. Min L., Shu-ming J., Zheng T., et al. C4d-positive acute humoral renal allograft rejection: rescue therapy by immunoadsorption in combination with tacrolimus and mycophenolate mofetil. Clin Transplant 18 (2004) 536
7. Racusen L.C., Solez K., Colvin R.B., et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 55 (1999) 13
8. Rodrigo E., Escallada R., Ferna'ndez-Fresnedo G., et al. Histopathological findings according to Banff-97 classification system comparing tacrolimus versus cyclosporine. Transplantation Proc 34 (2002) 1719
9. Cortesini R. Cyclosporine-Lessons from the first 20 years. Transplantation Proc 36 suppl 2S (2004) 158S
10. Lucan M., Iacob G., Lucan C., et al. Ten years of cyclosporine use in renal transplantation: a single-center experience with 479 renal transplants. Transplantation Proc 36 suppl 2S (2004) 177S
11. Mizuiri S., Iwamoto M., Miyagi M., et al. Activation of nuclear factor-kappa B and macrophage invasion in cyclosporin A and tacrolimus-treated renal transplants. Clin Transplant 18 (2004) 14
12. Van Duijnhoven E.M., Christiaans M.H.L., Boots O.M.M., et al. Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression. J Am Soc Nephrol 13 (2002) 213
13. Pichlmayr R., Winkler M., Neuhaus P., et al. Three-year follow-up of the European multicentre tacrolimus FK506 liver study. Transplant Proc 29 (1997) 2399
14. Chamienia A., Biedunkiewicz B., Król E., et al. One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimus. Transplant Proc 38 (2006) 81
15. Jiang H., Yang X.F., Soriano R., et al. inhibition of IL-10 by FK 506 may be responsible for overcoming ongoing allograft rejection in the rat. Transplantation Proc 31 (1999) 1203
16. Murphy G.J., Waller J.R., Sandford R.S., et al. Randomized clinical trial of the effect of microemulsion cyclosporin and tacrolimus on renal allograft fibrosis. Br J Surg 90 (2003) 680
17. Yang C.W., Ahn H.J., Jung J.Y., et al. Reconditioning with cyclosporine A or FK506 differentially regulates mitogen-activated protein kinase expression in rat kidneys with ischemia/reperfusion injury. Transplantation 75 (2003) 20
18. Singh N., and Heitman J. Antifungal attributes of immunosuppressive agents:new paradigms in management and elucidating the pathphysiologic basis of opportunistic mycoses in organ transplant recipients. Transplantation 77 (2004) 795
19. Sonnoda T., Takahara S., Takhashi K., et al. Outcome of 3 years of immunosuppression with tacrolimus in more than 1,000 renal transplant recipients in Japan. Transplantation 75 (2003) 199